Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/15/2003US20030091538 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
05/15/2003US20030091534 Adenoviral vectors having a protein IX deletion
05/15/2003US20030091532 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAS and polypeptides
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003US20030091507 Antidiabetic agents; side effect reduction
05/15/2003CA2782864A1 Compositions from the grasses lolium perenne and festuca arundinacea
05/15/2003CA2505129A1 Pharmaceutical compositions of marine sponge microciona prolifera
05/15/2003CA2466595A1 Protein knobs
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466391A1 Polyamide modulators of cox2 transcription
05/15/2003CA2466334A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003CA2466333A1 Method of proliferation in neurogenic regions
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466050A1 Polyvalent immunogen
05/15/2003CA2466049A1 Human monoclonal antibodies to dendritic cells
05/15/2003CA2465981A1 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003CA2465953A1 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003CA2465951A1 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003CA2465949A1 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
05/15/2003CA2465921A1 Novel compositions and methods for cancer
05/15/2003CA2465862A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003CA2465839A1 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
05/15/2003CA2465828A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
05/15/2003CA2465731A1 Screening for hepatitis c virus entry inhibitors
05/15/2003CA2465724A1 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
05/15/2003CA2465679A1 High level constitutive production of anthrax protective antigen
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464736A1 Beta-secretase inhibitors and methods of use
05/15/2003CA2464470A1 Novel epidermal growth factor protein and gene, and methods of use therefor
05/15/2003CA2463855A1 Weed controller metabolism proteins, genes thereof and use of the same
05/15/2003CA2463705A1 Method of selecting hla-dp4 ligands and the applications thereof
05/15/2003CA2463325A1 Novel proteins and nucleic acids encoding same
05/15/2003CA2462653A1 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
05/15/2003CA2462462A1 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003CA2460653A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2429147A1 Radiosensitivity enhancers, radiosensitivity-enhancing nucleic acids and proteins in cancer radiotherapy
05/14/2003EP1310798A2 Cell tests and diagnostic index for Alzheimer's disease
05/14/2003EP1310796A2 Reagents for the simultaneous detection of HCV core antigens and antibodies
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310560A1 Method of modifying microorganism-origin transglutaminase
05/14/2003EP1310559A1 Process for the production of alpha interferon of therapeutical degree
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310557A1 Design of bioactive peptides based on immunoglobulin structure
05/14/2003EP1310554A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
05/14/2003EP1310553A1 Method of estimating the genotype of fertility recovery locus to rice bt type male fertility cytoplasm
05/14/2003EP1310551A1 Virus-like micrograins and process for producing the same
05/14/2003EP1310512A2 Hcv core protein sequences
05/14/2003EP1310511A2 Oligopeptides for promoting hair growth
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1309869A1 Designing and screening random libraries of compounds
05/14/2003EP1309860A2 Method for screening peptides for use in immunotherapy
05/14/2003EP1309727A2 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease
05/14/2003EP1309725A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver
05/14/2003EP1309724A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells
05/14/2003EP1309723A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and hbl 100 cells
05/14/2003EP1309718A2 Neutrokine-alpha and neutrokine-alpha splice variant
05/14/2003EP1309716A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
05/14/2003EP1309712A2 Composition and method for increased meiotic recombination in plants
05/14/2003EP1309708A2 Method for altering degradation of engineered protein in plant cells
05/14/2003EP1309694A2 Method for improved production of cyanophycin and the secondary products thereof
05/14/2003EP1309690A2 Mfq-111, a novel human gtpase like protein
05/14/2003EP1309689A2 Genes involved in immune related responses observed with asthma
05/14/2003EP1309688A2 G protein-coupled receptors
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309686A2 Slgp protein and nucleic acid molecules and uses therefor
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309682A2 Tetraspan protein and uses thereof
05/14/2003EP1309680A2 Dna & protein binding miniature proteins
05/14/2003EP1309679A2 Human genes and gene expression products
05/14/2003EP1309626A2 Cng2b: a putative human cyclic nucleotide-gated ion channel
05/14/2003EP1309625A2 Therapeutic compounds for ovarian cancer
05/14/2003EP1309624A2 Hcn polypeptides and polynukleotides and their use in therapy
05/14/2003EP1309623A2 G protein-coupled receptors from human clone "26908" and uses thereof
05/14/2003EP1309622A2 Lat peptides and their use in assays for identifying immunosuppressants
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309619A1 New nucleotide sequences coding for the lysr1 gene
05/14/2003EP1309618A2 Leucine-based motif and clostridial neurotoxins
05/14/2003EP1309617A2 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof
05/14/2003EP1309616A1 Integrin binding motif containing peptides and methods of treating skeletal diseases
05/14/2003EP1309614A2 Novel secreted proteins and their uses
05/14/2003EP1309612A2 Pseudo-metalloproteins, corresponding preparation and use as biosensors
05/14/2003EP1309610A2 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii
05/14/2003EP1309608A2 Novel peptides and methods of use
05/14/2003EP1309607A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
05/14/2003EP1309606A1 T1r taste receptors and genes encoding same
05/14/2003EP1309604A2 Phage-dependent superproduction of biologically active protein and peptides
05/14/2003EP1309603A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof
05/14/2003EP1309602A2 Malaria immunogen and vaccine
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1309342A2 Production of chimeric human papillomavirus
05/14/2003EP1309341A2 Prevention and treatment of alzheimer's disease
05/14/2003EP1309338A1 Pharmaceutical composition comprising trkaig2 for use in the prevention and/or treatment of cancer
05/14/2003EP1309337A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage
05/14/2003EP1280814A4 Association of beta2 adrenergic receptor haplotypes with drug response
05/14/2003EP1162875B1 Plants transformed with thioredoxin
05/14/2003EP1155117A4 Secreted proteins and nucleic acids encoding them
05/14/2003EP1140987B1 Peptides for inhibiting hpv e6 proteins
05/14/2003EP1107787B1 Salmonella typhi vaccine compositions
1 ... 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 ... 2916